This is a routine investor presentation filing with no new financial data or guidance. Monitor for any subsequent material disclosures or clinical/regulatory updates that may be referenced in the presentation.
Price Chart
Executive Summary
Dare Bioscience filed an 8-K on October 1, 2026, to furnish a corporate investor presentation (Exhibit 99.1) under Item 7.01 Regulation FD. The presentation is intended for use in meetings with securities market participants. No financial data, guidance, or material business updates were disclosed in the filing text.
Key Facts
- Filed 8-K on October 1, 2026, with Item 7.01 Regulation FD Disclosure
- Furnished a corporate investor presentation (Exhibit 99.1) dated October 1, 2026
- Presentation will be used in meetings with securities market participants
- No financial results, guidance, or material agreements disclosed in the filing text
- Presentation content is not incorporated by reference into SEC filings
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- No material information disclosed — stock may trade on presentation content if it contains pipeline updates
- Clinical-stage biotech with no revenue — valuation depends on pipeline progress
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-045275 |
| Document: form8-k.htm | 0001493152-26-045275 |
| Document: 0001493152-26-045275-index-headers.html | 0001493152-26-045275 |
| Document: 0001493152-26-045275-index.html | 0001493152-26-045275 |
| Document: 0001493152-26-045275.txt | 0001493152-26-045275 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers